Session Details

[3T07]Lipid Biology 04

Wed. Nov 5, 2025 10:50 AM - 11:50 AM JST
Wed. Nov 5, 2025 1:50 AM - 2:50 AM UTC
Room7(Room C-1)
Organizers:Takehiro Yamamoto(Central Institute for Experimental Medicine and Life Science), Ikuyo Ichi(Ochanomizu University)

[3T07-01]Lysophosphatidic acid stimulates CX3CL1 secretion from lymphatic endothelial cells and regulates immunopathology

Atsuki Taira, Daisuke Yasuda, Nana Sato, Satoshi Ishii (Department of Immunology, Akita University Graduate School of Medicine)
キーテクノロジー:Conditional knockout mice
Comment()

[3T07-02]Molecular mechanisms of lysophosphatidic acid-induced lymphatic valve development

Daisuke Yasuda1, Nana Sato1, Keisuke Yanagida2,3, Hideo Shindou2,4, Tomomi Hashidate-Yoshida2,4, Takao Shimizu2,5, Satoshi Ishii1 (1.Department of Immunology, Akita University Graduate School of Medicine, 2.Department of Lipid Life Science, National Institute of Global Health and Medicine, Japan Institute for Health Security, 3.Department of Molecular Biology, Faculty of Medicine, The Jikei University, 4.Departments of Medical Lipid Science, Graduate School of Medicine, The University of Tokyo, 5.Institute of Microbial Chemistry)
キーテクノロジー:Immunohistochemistry
Comment()

[3T07-03]Physiological significance of prostaglandins in early development of blood vessels

Soken Tsuchiya, Minori Noma, Sei Ma, Tomoaki Inazumi, Yukihiko Sugimoto (Department of Pharmaceutical Biochemistry, Graduate School of Pharmaceutical Sciences, Kumamoto University)
キーテクノロジー:ゲノム編集
Comment()

[3T07-04]PS-PLA1-LysoPS-LPS1 signaling axis enhances the anti-tumor effect mediated by intratumoral basophils

Shun Nishikado, Junpei Omi, Junken AoAoki (Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, The University of Tokyo)
キーテクノロジー:scRNA-seq, LC-MS/MS, FCM
Comment()

[3T07-05]Hearing impairment caused by deficiency of the DHA phospholipid synthesizing enzyme LPLAT3

Atsumu Teramura1,2, Tomoyuki Suzuki1, Keisuke Yanagida3, Teru Kamogashira2, Kenji Kondo2, Takao Shimizu1,4, Hideo Shindou1 (1.Department of Lipid Life Science, National Institute of Global Health and Medicine, Japan Institute for Health Security, 2.Department of Otolaryngology Head and Neck Surgery, Graduate School of Medicine, The University of Tokyo, 3.Department of Molecular Biology, Jikei University School of Medicine, 4.Institute of Microbial Chemistry)
キーテクノロジー:LCMS
Comment()

[3T07-06]sPLA2-XIIA is a novel drug target for Th17-driven immune diseases

Chika Mochizuki1, Yoshitaka Taketomi1, Junken Aoki2, Kuniyuki Kano2, Yusuke Endo3, Makoto Murakami1,4 (1.CDBIM, Grad. Sch. of Med., UTokyo, 2.Lab. of Health Chem., Grad. Sch. of Pharm. Sci., UTokyo, 3.Lab. Med. Omics Res., Kazusa DNA Res. Inst., 4.AMED-CREST)
キーテクノロジー:リピドミクス
Comment()